![]() |
市场调查报告书
商品编码
1803077
全球乳製品检测市场:预测(至 2032 年)-按检测类型、产品类型、技术、最终用户和地区进行分析Dairy Testing Market Forecasts to 2032 - Global Analysis By Test Type (Safety Testing and Quality Testing), Product Type, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,全球乳製品检测市场预计在 2025 年达到 75 亿美元,到 2032 年将达到 148.1 亿美元,预测期内的复合年增长率为 10.2%。
乳製品检测是分析牛奶和乳製品以确保其品质、安全性和符合监管标准的过程。这包括检测污染物、验证营养成分以及评估成分、微生物品质和掺假等参数。乳製品检测采用先进的分析技术,有助于保持产品的一致性、延长保质期并保护消费者健康,同时帮助生产商满足产业和政府对生产安全、高品质乳製品的要求。
据英国国家统计局称,2022 年英国英国使用该系统对约 1,200 万个样本进行残留检测。
生牛奶掺假和污染增加
生鲜牛奶掺假是一个普遍存在的问题,尤其是在乳製品消费量高的地区。生鲜牛奶中常发现淀粉、清洁剂和合成化学物质等有害物质,构成严重的健康风险。为此,相关部门正在加强监管,并在生产和分销管道实施更严格的检测。这种转变推动了对全面安全评估的需求,包括病原体和残留物检测。乳製品公司正在采用日益复杂的检测系统,以满足合规性并建立消费者信任。随着公众关注度的不断提高,检测正在从被动的安全措施转变为主动的品管措施。
缺乏熟练的乳製品检验专业人员
乳製品产业持续面临缺乏能够胜任复杂乳製品检测程序的合格人员的困境。许多开发中地区的食品安全技术培训和教育仍然有限。小型生产商往往缺乏标准化检测的专业知识,导致产品品质不稳定。技术纯熟劳工的短缺也影响了检测结果的准确性和可靠性,尤其是在微生物和化学分析方面。这种劳动力短缺减缓了检测服务的扩展,并使法规遵循变得更加复杂。
提高营养品质意识
注重健康的消费者越来越重视乳製品的营养成分。因此,检测营养成分和标籤的准确性正成为製造商的首要任务。都市区和年轻消费者尤其青睐洁净标示、富含蛋白质和强化乳製品。监管机构要求更清晰的标籤,并敦促生产商透过严格的检测来检验营养声明。功能性乳製品的出现进一步增加了可靠营养分析的需求。这种日益增长的意识使乳製品检测成为产品真实性和市场差异化的策略工具。
原料乳供应波动影响检测需求
季节性波动、饲料短缺以及天气相关的干扰往往会导致牛奶产量不稳定,影响进入检测流程的产品数量。当供应下降时,加工商会减少产量或延迟品质检查,导致检查週期不稳定。这种不一致性会降低实验室效率,并使检测供应商的资源规划变得复杂。小型酪农尤其容易受到影响,因为它们缺乏在供应衝击期间维持稳定运作的缓衝能力。因此,牛奶供应的波动会导致检测需求不稳定,并造成整个价值链效率低落。
疫情导致乳製品物流严重中断,餐旅服务业需求下降,引发劳动力短缺。出行限制延误了样本采集和实验室检测,影响了整体效率。同时,消费者偏好转向更安全的包装乳製品,这增加了对严格检测的需求。实验室采取了应对措施,采用数位平台和远端监控工具来维持营运。线上零售和追溯系统日益普及,使买家对产品安全充满信心。
病原体检测领域预计将在预测期内达到最大规模
预计病原体检测领域将在预测期内占据最大的市场占有率,这得益于乳製品对先进病原体检测的需求。监管压力正推动产业朝向更快、更精准的工具发展,例如生物感测器、ELISA 和基于 PCR 的方法。实验室晶片系统、自动化工作流程和即时监控等技术创新正日益普及。政府主导的生鲜乳安全计画也正在推动早期检测工作。综上所述,这些发展使得病原体筛检对于确保乳製品的完整性和保障公众健康至关重要。
预计独立测试实验室部门在预测期内将实现最高的复合年增长率
预计独立检测领域将在预测期内达到最高成长率。这是因为在监管要求日益严格以及对污染日益担忧的背景下,对公正且准确的分析的需求日益增长。越来越多的酪农生产商开始寻求第三方检测实验室的认证和可靠结果。这些实验室整合了酶联免疫吸附试验 (ELISA)、生物感测器和微流体系统等尖端工具,以提高速度和准确性。数位化自动化、数据主导的洞察和远端样本采集等趋势正在蓬勃发展。随着公共检测的减少,该行业正在转向依赖认证的私人实验室来确保合规性和安全性。
预计亚太地区将在预测期内占据最大的市场占有率,这得益于乳製品消费量的增长、更严格的安全法规以及日益增长的公共卫生问题。生物感测器、ELISA和基于PCR的工具等先进技术正被广泛采用,以实现更快、更准确的诊断。人工智慧监控、自动化工作流程和远端样本采集等趋势正在重塑检测实践。监管改革、实验室扩建和策略联盟等发展使得私人和机构实验室对于保障全部区域酪农的品质至关重要。
预计北美将在预测期内实现最高的复合年增长率。这是由于日益增长的安全担忧、反覆出现的污染案例以及更严格的法律规范。随着联邦原料乳监测计画的缩减,人们越来越依赖认可的独立实验室。生物感测器、ELISA 和 PCR 等最尖端科技正被用于快速检测病原体和毒素。关键趋势包括即时监测、自动化系统和微流体平台。实验室扩建、策略合作伙伴关係和高级分析等最新进展正在巩固检测作为乳製品品质保证的重要组成部分的地位。
According to Stratistics MRC, the Global Dairy Testing Market is accounted for $7.50 billion in 2025 and is expected to reach $14.81 billion by 2032 growing at a CAGR of 10.2% during the forecast period. Dairy testing is the process of analyzing milk and dairy products to ensure quality, safety, and compliance with regulatory standards. It involves detecting contaminants, verifying nutritional content, and assessing parameters such as composition, microbiological quality, and adulteration. Using advanced analytical techniques, dairy testing helps maintain product consistency, extend shelf life, and protect consumer health, while supporting producers in meeting industry and government requirements for safe and high-quality dairy production.
According to the U.K Office for National Statistics, approximately 12 million samples were tested for residue by the system in the U.K. in 2022.
Increasing incidence of milk adulteration and contamination
Milk adulteration is becoming a widespread issue, particularly in regions with high dairy consumption. Harmful substances like starch, detergents, and synthetic chemicals are frequently found in milk, posing serious health hazards. In response, authorities are tightening regulations and enforcing more rigorous testing across production and distribution channels. This shift is driving demand for comprehensive safety assessments, including pathogen and residue detection. Dairy companies are increasingly adopting advanced testing systems to meet compliance and build consumer confidence. As public concern grows, testing is transitioning from a reactive safeguard to a proactive quality control measure.
Lack of skilled professionals for dairy testing
The industry continues to struggle with a lack of qualified personnel capable of handling complex dairy testing procedures. In many developing areas, technical training and education in food safety remain limited. Small producers often lack the expertise to implement standardized testing, resulting in inconsistent product quality. The shortage of skilled workers also affects the accuracy and reliability of test results, particularly in microbiological and chemical analysis. This talent gap slows down the expansion of testing services and complicates regulatory adherence.
Growing awareness about nutritional quality
Health-conscious consumers are placing greater emphasis on the nutritional content of dairy products. As a result, testing for nutrient composition and label accuracy is becoming a key priority for manufacturers. Urban populations and younger buyers are especially drawn to clean-label, protein-rich, and fortified dairy options. Regulatory agencies are pushing for clearer labeling, prompting producers to validate their nutritional claims through precise testing. The emergence of functional dairy products further amplifies the need for robust nutrient analysis. This growing awareness positions dairy testing as a strategic tool for product credibility and market differentiation.
Fluctuations in raw milk supply affecting testing demand
Seasonal variations, feed shortages, and climate-related disruptions often lead to unpredictable milk yields, impacting the volume of products entering the testing pipeline. When supply dips, processors may reduce production or delay quality checks, leading to uneven testing cycles. This inconsistency hampers laboratory efficiency and complicates resource planning for testing providers. Smaller dairies are particularly vulnerable, as they lack buffer capacity to maintain steady operations during supply shocks. As a result, fluctuating raw milk supply undermines the stability of testing demand and creates operational inefficiencies across the value chain.
The pandemic caused major disruptions in dairy logistics, reduced demand from hospitality sectors, and led to workforce shortages. Restrictions on movement delayed sample collection and lab testing, affecting overall efficiency. At the same time, consumer preference shifted toward packaged and safer dairy products, increasing the need for stringent testing. Laboratories responded by adopting digital platforms and remote monitoring tools to maintain operations. Online retail and traceability systems gained traction, allowing buyers to verify product safety.
The pathogen testing segment is expected to be the largest during the forecast period
The pathogen testing segment is expected to account for the largest market share during the forecast period, due to the need for advanced pathogen testing in dairy products. Regulatory pressure is pushing the industry toward faster, more precise tools like biosensors, ELISA, and PCR-based methods. Innovations such as lab-on-chip systems, automated workflows, and real-time monitoring are gaining traction. Government-led milk safety programs are also boosting early detection efforts. Collectively, these developments are making pathogen screening essential for ensuring dairy integrity and safeguarding public health.
The independent laboratories segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the independent laboratories segment is predicted to witness the highest growth rate, driven by the need for impartial, high-accuracy analysis amid growing regulatory demands and contamination concerns. Dairy producers are turning to third-party labs for certified, dependable results. These facilities are integrating cutting-edge tools like ELISA, biosensors, and microfluidic systems to enhance speed and precision. Trends such as digital automation, data-driven insights, and remote sample collection are gaining momentum. With reduced public testing, industry trust is shifting toward accredited private labs for compliance and safety.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, owing to growing dairy consumption, stricter safety regulations, and increasing public health concerns. Advanced technologies such as biosensors, ELISA, and PCR-based tools are being widely adopted for faster, more accurate diagnostics. Trends like AI-enabled monitoring, automated workflows, and remote sample collection are reshaping testing practices. Developments like regulatory reforms, lab expansions, and strategic collaborations are positioning both private and institutional labs as essential players in safeguarding dairy quality across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to heightened safety concerns, recurring contamination cases, and stricter regulatory frameworks. With federal milk surveillance programs scaled back, reliance on certified independent labs has surged. Cutting-edge technologies like biosensors, ELISA, and PCR are being deployed for rapid detection of pathogens and toxins. Key trends include real-time monitoring, automated systems, and microfluidic platforms. Recent developments such as lab expansions, strategic alliances, and advanced analytics are solidifying testing as a vital element of dairy quality assurance.
Key players in the market
Some of the key players in Dairy Testing Market include Eurofins Scientific, Agilent Technologies, Inc., SGS S.A., Bio-Rad Laboratories, Inc., Intertek Group plc, Charm Sciences, Inc., Bureau Veritas S.A., Thermo Fisher Scientific Inc., Merieux NutriSciences Corporation, TUV NORD GROUP, ALS Limited, TUV SUD, Neogen Corporation, Romer Labs Division Holding GmbH, and AsureQuality.
In July 2025, Thermo Fisher Scientific Inc. announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. Under the agreement, Thermo Fisher will acquire Sanofi's steriles manufacturing site in Ridgefield, New Jersey and will continue to manufacture a portfolio of therapies for Sanofi.
In June 2025, Intertek has acquired an Automated Breathing Metabolic Simulator (ABMS) from ATOR Labs to further expand its respirator testing capabilities. One of only nine such systems in use globally, this cutting-edge technology empowers Intertek to deliver high-precision testing, accelerated development cycles, and streamlined compliance with global standards to respirator manufacturers, solidifying its leadership in respiratory protective device (RPD) testing.
In April 2025, Agilent Technologies Inc. announced its participation at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.